Quality of life after rectal resection and multimodality therapy

Journal of Surgical Oncology

Volumn 96, Issue 8, 2007, Pages 684-692

  Hassan, Imran ^a   Cima, Robert R ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bowel function; Chemotherapy; Pelvic radiotherapy; Surgery

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

ADVANCED CANCER; ARTERY EMBOLISM; ARTERY THROMBOSIS; BLADDER FUNCTION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COLOSTOMY; CONTINUOUS INFUSION; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; FEMALE SEXUAL DYSFUNCTION; HUMAN; HYPERTENSION; MALE SEXUAL DYSFUNCTION; NAUSEA; NEUROTOXICITY; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RECTUM CANCER; RECTUM SURGERY; REVIEW; SEXUAL FUNCTION; STOMATITIS; WOUND HEALING IMPAIRMENT;

CHEMOTHERAPY, ADJUVANT; COLOSTOMY; HUMANS; NEOADJUVANT THERAPY; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RECTUM;

EID: 38149129453     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20916     Document Type: Review

References (62)

1. Sprangers MA: Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 2002;41.229-237.
2. Jacobsen PB, Davis K, Cella D: Assessing quality of life in research and clinical practice. Oncology (Williston Park) 2002; 16:133-139.
3. Michael M, Tannock IF: Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. CMAJ 1998;158:1727-1734.
4. Whalen GF, Ferrans CE: Quality of life as an outcome in clinical trials and cancer care: A primer for surgeons. J Surg Oncol 2001; 77:270-276.
5. Frost MH, Sloan JA: Quality of life measurements: A soft outcome-or is it? Am J Manag Care 2002;8:S574-S579.
6. Wyrwich KW, Tierney WM, Wolinsky FD: Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999;52:861-873.
7. Soni MK, Cella D: Quality of life and symptom measures in oncology: An overview. Am J Manag Care 2002;8:S560-S573.
8. Haddock MG, Sloan JA, Bollinger JW, et al.: Patient assessment of bowel function during and after pelvic radiotherapy: Results of a prospective phase III North Central Cancer Treatment Group clinical trial. J Clin Oncol 2007;25:1255-1259.
9. Camilleri-Brennan J, Steele RJ: Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. Br J Surg 2001;88:1617-1622.
10. Morris AM: Patient-centered outcomes after therapy for colorectal cancer. Surg Oncol Clin N Am 2006;15:195-211.
11. Anthony T, Hynan LS, Rosen D, et al.: The association of pretreatment health-related quality of life with surgical complications for patients undergoing open surgical resection for colorectal cancer. Ann Surg 2003;238:690-696.
12. Holloway S, Sarosi G, Kim L, et al.: Health-related quality of life and postoperative length of stay for patients with colorectal cancer. J Surg Res 2002;108:273-278.
13. Quah HM, Jayne DG, Eu KW, et al.: Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg 2002;89:1551-1556.
14. Lindsey I, Guy RJ, Warren BF, et al.: Anatomy of Denonvilliers' fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg 2000;87:1288-1299.
15. Havenga K, Maas CP, DeRuiter MC, et al.: Avoiding long-term disturbance to bladder and sexual function in pelvic surgery, particularly with rectal cancer. Semin Surg Oncol 2000;18:235-243.
16. Hendren SK, O'Connor BI, Liu M, et al.: Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005;242:212-223.
17. Jayne DG, Brown JM, Thorpe H, et al.: Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg 2005;92:1124-1132.
18. Engel J, Kerr J, Schlesinger-Raab A, et al.: Quality of life in rectal cancer patients: A four-year prospective study. Ann Surg 2003; 238:203-213.
19. Camilleri-Brennan J, Steele RJ: Quality of life after treatment for rectal cancer. Br J Surg 1998;85:1036-1043.
20. Sprangers MA, Taal BG, Aaronson NK, et al.: Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum 1995;38:361-369.
21. Jess P, Christiansen J, Bech P: Quality of life after anterior resection versus abdominoperineal extirpation for rectal cancer. Scand J Gastroenterol 2002;37:1201-1204.
22. Kim NK, Aahn TW, Park JK, et al.: Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer. Dis Colon Rectum 2002;45:1178-1185.
23. Breukink SO, van der Zaag-Loonen HJ, Bouma EM, et al.: Prospective evaluation of quality of life and sexual functioning after laparoscopic total mesorectal excision. Dis Colon Rectum 2007;50:147-155.
24. Graf W, Ekstrom K, Glimelius B, et al.: A pilot study of factors influencing bowel function after colorectal anastomosis. Dis Colon Rectum 1996;39:744-749.
25. Camilleri-Brennan J, Steele RJ: Objective assessment of morbidity and quality of life after surgery for low rectal cancer. Colorectal Dis 2002;4:61-66.
26. Wheeler JM, Mc CMNJ: Reconstructive rectal surgery. Surg Oncol 1998;7:13-23.
27. Grumann MM, Noack EM, Hoffmann IA, et al.: Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 2001;233: 149-156.
28. McDonald PJ, Heald RJ: A survey of postoperative function after rectal anastomosis with circular stapling devices. Br J Surg 1983; 70:727-729.
29. Pachler J, Wille-Jorgensen P: Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev 2005: CD004323.
30. Fazio VW, Heriot AG: Proctectomy with coloanal anastomosis. Surg Oncol Clin N Am 2005;14:157-181.
31. Hassan I, Larson DW, Cima RR, et al.: Long-term functional and quality of life outcomes after coloanal anastomosis for distal rectal cancer. Dis Colon Rectum 2006;49:1266-1274.
32. Kuzu MA, Topcu O, Ucar K, et al.: Effect of sphincter-sacrificing surgery for rectal carcinoma on quality of life in Muslim patients. Dis Colon Rectum 2002;45:1359-1366.
33. Holzer B, Matzel K, Schiedeck T, et al.: Do geographic and educational factors influence the quality of life in rectal cancer patients with a permanent colostomy? Dis Colon Rectum 2005; 48:2209-2216.
34. Rockwood TH, Church JM, Fleshman JW, et al.: Fecal Incontinence Quality of Life Scale: Quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 2000;43: 9-16; discussion 16-7.
35. Lindsey I, Mortensen NJ: Iatrogenic impotence and rectal dissection. Br J Surg 2002;89:1493-1494.
36. Nesbakken A, Nygaard K, Bull-Njaa T, et al.: Bladder and sexual dysfunction after mesorectal excision for rectal cancer. Br J Surg 2000;87:206-210.
37. Havenga K, Enker WE, McDermott K, et al.: Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996;182:495-502.
38. Marijnen CA, van de Velde CJ, Putter H, et al.: Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial. J Clin Oncol 2005;23:1847-1858.
39. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358: 1291-1304.
40. Camma C, Giunta M, Fiorica F, et al.: Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. Jama 2000;284: 1008-1015.
41. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. Jama 1990;264:1444-1450.
42. Monga DK, O'Connell MJ: Surgical adjuvant therapy for colorectal cancer: Current approaches and future directions. Ann Surg Oncol 2006;13:1021-1034.
43. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336:980-987.
44. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
45. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
46. Peeters KC, van de Velde CJ, Leer JW, et al.: Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients - A Dutch colorectal cancer group study. J Clin Oncol 2005;23:6199-6206.
47. Dahlberg M, Glimelius B, Graf W, et al.: Preoperative irradiation affects functional results after surgery for rectal cancer: Results from a randomized study. Dis Colon Rectum 1998;41:543-549; discussion 549-551.
48. Kollmorgen CF, Meagher AP, Wolff BG, et al.: The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994;220:676-682.
49. Lundby L, Krogh K, Jensen VJ, et al.: Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Dis Colon Rectum 2005;48:1343-1349 discussion 1349-52; author reply 1352.
50. Bonnel C, Parc YR, Pocard M, et al.: Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function. Dis Colon Rectum 2002;45:934-939.
51. Beard CJ, Lamb C, Buswell L, et al.: Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:257-262.
52. Little DJ, Kuban DA, Levy LB, et al.: Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology 2003;62:707-713.
53. Vale J: Erectile dysfunction following radical therapy for prostate cancer. Radiother Oncol 2000;57:301-305.
54. Bosset JF, Collette L, Calais G, et al.: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355:1114-1123.
55. Sebag-Montefiore D: Developments in the use of chemoradiotherapy in rectal cancer. Colorectal Dis 2006;8:14-17.
56. Kopec JA, Yothers G, Ganz PA, et al.: Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: Results from National Surgical Adjuvant Breast and Bowel Project Trial C-06. J Clin Oncol 2007;25:424-430.
57. Goldberg RM, Sargent DJ, Morton RF, et al.: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23-30.
58. Grothey A, Sargent D, Goldberg RM, et al.: Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004;22:1209-1214.
59. Goldberg RM, Gill S: Recent phase III trials of fluorouracil, irinotecan,' and oxaliplatin as chemotherapy for metastatic colorectal cancer. Cancer Chemother Pharmacol 2004;54:S57-S64.
60. Thornton AD, Ravn P, Winslet M, et al.: Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer. Br J Surg 2006;93:1456-1463.
61. Urso E, Serpentini S, Pucciarelli S, et al.: Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer. Eur J Surg Oncol 2006;32: 1201-1208.
62. Moinpour CM: Do quality of life assessments make a difference in the evaluation of cancer treatments? Control Clin Trials 1997; 18:311-317.